Sign in

CIK 0001830214

  • Accelerated filer

Ginkgo Bioworks Holdings, Inc.

Sign in to watch
Ticker
DNA
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
872652913
Phone
+1 877-442-5362
Business address
27 DRYDOCK AVENUE, 8TH FLOOR, BOSTON, MA, 02210
Former names
Soaring Eagle Acquisition Corp., Spinning Eagle Acquisition Corp.
  1. 4 Planned sale 10% owner sold 75,300 shares at an average $1.94 ($146,082)
  2. 4 Planned sale See remarks sold 75,300 shares at an average $1.94 ($146,082)
  3. 4 Planned sale Director sold 39,007 shares at $1.84 ($71,773)
  4. 4 Planned sale See remarks sold 75,300 shares at an average $1.77 ($132,980)
  5. 4 Planned sale See remarks sold 200,000 shares at an average $1.77 ($353,200)
  6. 4 Planned sale 10% owner sold 75,300 shares at an average $1.77 ($132,980)
  7. 4 Planned sale Director sold 4,499 shares at $1.63 ($7,333)
  8. 4 Open-market sale See remarks sold 40,511 shares at $1.57 ($63,400)
  9. 4 Planned sale See remarks sold 75,300 shares at an average $1.64 ($123,116)
  10. 4 Planned sale See remarks sold 200,000 shares at an average $1.64 ($327,000)
  11. 4 Planned sale 10% owner sold 75,300 shares at an average $1.64 ($123,116)
  12. 4 Planned sale See remarks sold 75,300 shares at an average $1.54 ($116,075)
  13. 4 Planned sale 10% owner sold 75,300 shares at an average $1.54 ($116,075)
  14. 4 Planned sale See remarks sold 200,000 shares at an average $1.54 ($308,100)
  15. 4 Planned sale See remarks sold 250,000 shares at $1.50 ($375,000)
  16. 4 Open-market buy Director bought 400,000 shares at $1.28 ($512,000)
  17. 4 Open-market buy Director bought 350,000 shares at $1.28 ($448,000)
  18. 3 Insider Initial Statement of Ownership
  19. 4 Planned sale See remarks sold 75,300 shares at an average $1.28 ($96,271)
  20. 4 Planned sale See remarks sold 200,000 shares at an average $1.28 ($255,700)

Page 11 of 24 · 474 filings